| scholarly article | Q13442814 |
| P50 | author | Anthony B Pinkerton | Q56491238 |
| Marc Caron | Q64858849 | ||
| P2093 | author name string | William C Wetsel | |
| Michael P Hedrick | |||
| Paul Hershberger | |||
| Satyamaheshwar Peddibhotla | |||
| Thomas D Y Chung | |||
| Ramona M Rodriguiz | |||
| James B Thomas | |||
| Yushi Bai | |||
| Glen R Hanson | |||
| Larry S Barak | |||
| Sean Peterson | |||
| Nikhil M Urs | |||
| Patrick R Maloney | |||
| Tama Evron | |||
| P2860 | cites work | The 100-kDa neurotensin receptor is gp95/sortilin, a non-G-protein-coupled receptor | Q22003873 |
| Cloning and expression of a complementary DNA encoding a high affinity human neurotensin receptor | Q24314254 | ||
| Structure, functional expression, and cerebral localization of the levocabastine-sensitive neurotensin/neuromedin N receptor from mouse brain | Q24320397 | ||
| A rapid and affordable screening platform for membrane protein trafficking. | Q27305088 | ||
| Structural Basis for Allosteric Regulation of GPCRs by Sodium Ions | Q27670746 | ||
| Neurotensin and neurotensin receptors | Q28138527 | ||
| Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis* | Q28208920 | ||
| Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system. | Q40473940 | ||
| Novel predictions from radiation target analysis | Q40767419 | ||
| Modeling of bias for the analysis of receptor signaling in biochemical systems | Q41098045 | ||
| Knockout mice and dirty drugs. Drug addiction | Q41110811 | ||
| The complex regulation of receptor-coupled G-proteins | Q41650513 | ||
| Structure and functional expression of the cloned rat neurotensin receptor | Q41733457 | ||
| In vivo neurochemical and behavioural effects of intracerebrally administered neurotensin and D-Trp11-neurotensin on mesolimbic and nigrostriatal dopaminergic function in the rat. | Q41917716 | ||
| Half a million Americans use methamphetamine every week | Q42953279 | ||
| Immunohistochemical distribution of NTS2 neurotensin receptors in the rat central nervous system | Q44441072 | ||
| Neuroprotective effect of the neurotensin analogue JMV-449 in a mouse model of permanent middle cerebral ischaemia | Q44659047 | ||
| Differential response of neurotensin to methamphetamine self-administration | Q46258484 | ||
| Novel antipsychotic-like effects on prepulse inhibition of startle produced by a neurotensin agonist | Q46510974 | ||
| How a G protein binds a membrane | Q47406110 | ||
| Tissue distribution and cellular localization of the levocabastine-sensitive neurotensin receptor mRNA in adult rat brain | Q47798016 | ||
| Mechanism of modulation of [3H]raclopride binding to dopaminergic receptors in rat striatal membranes by sodium ions | Q48702674 | ||
| Localization of neuropeptide receptor mRNA in rat brain: Initial observations using probes for neurotensin and substance P receptors | Q48857796 | ||
| Effects of neurotensin on regional brain concentrations of dopamine, serotonin and their main metabolites | Q49092167 | ||
| Neurotransmitter regulation of dopamine neurons in the ventral tegmental area | Q72215317 | ||
| Positive versus negative modulation of different endogenous chemokines for CC-chemokine receptor 1 by small molecule agonists through allosteric versus orthosteric binding | Q81468834 | ||
| The Isolation of a New Hypotensive Peptide, Neurotensin, from Bovine Hypothalami | Q28245181 | ||
| A beta-arrestin/green fluorescent protein biosensor for detecting G protein-coupled receptor activation | Q28252768 | ||
| Molecular cloning of a levocabastine-sensitive neurotensin binding site | Q28280443 | ||
| Systemic administration of the neurotensin NTS₁-receptor agonist PD149163 improves performance on a memory task in naturally deficient male brown Norway rats | Q30397210 | ||
| The role of endogenous neurotensin in psychostimulant-induced disruption of prepulse inhibition and locomotion | Q30455967 | ||
| Diverse roles of neurotensin agonists in the central nervous system | Q30456105 | ||
| Contrasting trajectories of heroin, cocaine, and methamphetamine use. | Q33651986 | ||
| Teaching old receptors new tricks: biasing seven-transmembrane receptors | Q33985759 | ||
| Neurotensin regulates DARPP-32 thr34 phosphorylation in neostriatal neurons by activation of dopamine D1-type receptors | Q34133265 | ||
| Bacterial chemoreceptor arrays are hexagonally packed trimers of receptor dimers networked by rings of kinase and coupling proteins | Q34166081 | ||
| The role of hormone receptors and GTP-regulatory proteins in membrane transduction | Q34245912 | ||
| Neuropeptide receptor ligands as drugs for psychiatric diseases: the end of the beginning? | Q34275762 | ||
| Discovery of ML314, a Brain Penetrant Non-Peptidic β-Arrestin Biased Agonist of the Neurotensin NTR1 Receptor. | Q34409107 | ||
| G Protein and β-arrestin signaling bias at the ghrelin receptor | Q34580340 | ||
| Allosteric enhancers, allosteric agonists and ago-allosteric modulators: where do they bind and how do they act? | Q34581080 | ||
| Effect of methamphetamine self-administration on neurotensin systems of the basal ganglia | Q34702359 | ||
| Neurotensin agonists: possible drugs for treatment of psychostimulant abuse | Q35152140 | ||
| β-Arrestin-mediated receptor trafficking and signal transduction | Q35175384 | ||
| Distribution of neurotensin receptors in mammalian brain. What it is telling us about its interactions with other neurotransmitter systems | Q35273394 | ||
| Dimerization of the class A G protein-coupled neurotensin receptor NTS1 alters G protein interaction | Q35879672 | ||
| Crystal packing analysis of Rhodopsin crystals | Q35944832 | ||
| Fluoromodule-based reporter/probes designed for in vivo fluorescence imaging. | Q36165610 | ||
| Structure of the rhodopsin dimer: a working model for G-protein-coupled receptors | Q36433000 | ||
| CB(1) receptor allosteric modulators display both agonist and signaling pathway specificity. | Q36573169 | ||
| Response of neurotensin basal ganglia systems during extinction of methamphetamine self-administration in rat | Q37027017 | ||
| GPCR monomers and oligomers: it takes all kinds | Q37058647 | ||
| Allosteric modulators of GPCRs: a novel approach for the treatment of CNS disorders | Q37360436 | ||
| Biased agonism as a mechanism for differential signaling by chemokine receptors. | Q37368610 | ||
| The reversal of amphetamine-induced locomotor activation by a selective neurotensin-1 receptor agonist does not exhibit tolerance | Q37370136 | ||
| Imidazole-derived agonists for the neurotensin 1 receptor. | Q37502653 | ||
| Allostery and the Monod-Wyman-Changeux model after 50 years | Q37973759 | ||
| Structural determinants of arrestin functions | Q38114211 | ||
| Attenuation of cocaine-induced locomotor sensitization in rats sustaining genetic or pharmacologic antagonism of ghrelin receptors | Q38869715 | ||
| Distribution of neurotensin and its receptor in the central nervous system | Q40134265 | ||
| P433 | issue | 7 | |
| P921 | main subject | bias | Q742736 |
| P304 | page(s) | 1880-1890 | |
| P577 | publication date | 2016-05-05 | |
| P1433 | published in | ACS Chemical Biology | Q165583 |
| P1476 | title | ML314: A Biased Neurotensin Receptor Ligand for Methamphetamine Abuse | |
| P478 | volume | 11 |
| Q91496967 | A complex structure of arrestin-2 bound to a G protein-coupled receptor |
| Q47231111 | Biased signalling: from simple switches to allosteric microprocessors |
| Q39193257 | G Protein-Coupled Receptor Signaling Through β-Arrestin-Dependent Mechanisms |
| Q59138260 | Ghrelin Receptor Antagonism of Methamphetamine-Induced Conditioned Place Preference and Intravenous Self-Administration in Rats |
| Q47366066 | Orphan neuropeptides and receptors: Novel therapeutic targets |
| Q92692971 | Structure of the neurotensin receptor 1 in complex with β-arrestin 1 |
Search more.